Welcome
Support Centre
21 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Preventive effects of Transmural Integrated Care (TIC, 'ketenzorg') on disabled persons within homes of the elderly
ISRCTN ISRCTN11076857
DOI 10.1186/ISRCTN11076857
ClinicalTrials.gov identifier
EudraCT number
Public title Preventive effects of Transmural Integrated Care (TIC, 'ketenzorg') on disabled persons within homes of the elderly
Scientific title
Acronym Pikov
Serial number at source NTR544
Study hypothesis Transmural integrated care is effective on quality of life, functional health and disability.
Lay summary Not provided at time of registration
Ethics approval Received from local medical ethics committee
Study design Multicentre randomised open label active controlled crossover group trial
Countries of recruitment Netherlands
Disease/condition/study domain Activities of daily living (ADL) disabled, chronic disorder
Participants - inclusion criteria Persons who have at least one chronic disorder and are ADL-disabled.
Participants - exclusion criteria Terminally ill
Anticipated start date 01/01/2006
Anticipated end date 01/01/2008
Status of trial Completed
Patient information material
Target number of participants 166
Interventions TIC is operationalised in three sequential elements:
1. An in home multidimensional assessment is carried out by trained staff of the patient's functional health and care needs with the resident assessment instrument (RAI)
2. The assessment outcomes are discussed in a multidisciplinary consultation (MC). The MC presents individualised care plans to manage or treat modifiable disabilities and risk factors.
3. Consultation by a nursing home physician and psychologist is offered to the frailest residents at risk for nursing home admission (according to the RAI)

The control subjects receive care as usual.
Primary outcome measure(s) 1. Quality adjusted life years
2. Functional health
3. Disability
4. Cost effectiveness
Secondary outcome measure(s) 1. Admission to hospital and nursing home
2. Mortality
3. Patients care satisfaction
Sources of funding 1. VU University Medical Centre (VUMC) (Netherlands)
2. Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
3. West Fresian Area Care Group (Westfriese Zorggroep de Omring) (Netherlands)
Trial website
Publications 1. 2008 protocol in http://www.ncbi.nlm.nih.gov/pubmed/18606020
2. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21708967
3. 2012 cost-effectiveness analysis in http://www.ncbi.nlm.nih.gov/pubmed/22655047
Contact name Dr  M.  Boorsma
  Address Westfriese Zorggroep de Omring
Verpleeghuis Lindendael
Koepoortsweg 35
  City/town Hoorn
  Zip/Postcode 1624 AB
  Country Netherlands
  Email ma.boorsma@wxs.nl
Sponsor West Fresian Area Care Group (Westfriese Zorggroep de Omring) (Netherlands)
  Address Lindendael Nursing Home (Verpleeghuis Lindendael)
Koepoortsweg 35
  City/town Hoorn
  Zip/Postcode 1624 AB
  Country Netherlands
Date applied 14/02/2006
Last edited 28/09/2012
Date ISRCTN assigned 14/02/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.